4DMedical Limited (ASX:4DX) Signs Commercial Agreement with Qscan
Commercial Agreement Details
4DMedical Limited (ASX:4DX) has signed a significant commercial agreement with Qscan Radiology Clinics, a leading provider of diagnostic imaging services in Australia. The agreement follows a successful pilot programme that showcased the clinical and operational effectiveness of 4DMedical’s innovative respiratory imaging solutions.
This contract marks the first in Australia for 4DMedical to integrate products from both its Pulmonary Function and Pulmonary Structure suites. Included in this agreement are advanced diagnostic capabilities such as CT LVAS™, Lung Density Analysis™ – Inspiration (LDAi), Functional Lung Density Analysis™ (LDAf), and Lung Texture Analysis™ (LTA). The services will be available at selected Qscan practices in Brisbane, supporting clinicians and patients alike.
Executive Comments
Andreas Fouras, Managing Director and CEO of 4DMedical, expressed enthusiasm about the agreement. “This partnership ensures that more patients and clinicians have access to detailed, actionable insights into lung health, supporting better healthcare outcomes,” he stated. He also noted the ongoing momentum in the commercialisation of 4DMedical’s technology, aiming to expand their footprint in both the US and Australian markets.
Future Outlook
The commercial arrangement indicates a progressive step for 4DMedical as it continues to innovate within respiratory healthcare. By utilizing Software-as-a-Service models for reporting and billing, 4DMedical aims to streamline integration into existing medical infrastructures while enhancing access to its advanced imaging technologies across the country.
Motley Fool contributor Lianne Eastty has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
This article was generated using GPT-4o mini, a Large Language Model (LLM), to generate summaries of investing news. While AI is generating the content, we know better than to blindly trust our future robot overlords, and every article is edited and fact-checked by an editor holding the appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content of everything published by The Capital Club.